CTOs on the Move

Arkion Life Sciences

www.arkionls.com

 
Arkion Life Sciences is a New Castle, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.arkionls.com
  • 551 Mews Dr Ste J
    New Castle, DE USA 19720
  • Phone: 302.504.7400

Executives

Name Title Contact Details

Similar Companies

St Andrews Retirement Cmnty

St Andrews Retirement Cmnty is a Richmond, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Senior Home Health Care

Senior Home Health Care is a Commerce Township, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elevance Health

Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner.   Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health.  We believe that improving health for everyone is possible. It begins by redefining health, reimagining the health system, and strengthening our communities.

Insightra Medical

Insightra Medical is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Berg LLC

BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.